Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,764 | 11,476 | 22,100 | 7,394 | 3,741 |
| Gross Profit | 2,764 | 11,476 | 22,100 | 7,394 | 3,741 |
| Operating Expenses | 95,285 | 96,033 | 96,526 | 88,149 | 75,865 |
| Operating Income | -92,521 | -84,557 | -74,426 | -80,755 | -72,124 |
| Interest Expense | 98 | 108 | 72 | 59 | 60 |
| Other Income | 10,444 | 8,051 | 8,917 | 10,062 | 9,697 |
| Pre-tax Income | -82,175 | -76,614 | -65,581 | -70,752 | -62,487 |
| Net Income Continuous | -82,175 | -76,614 | -65,581 | -70,752 | -62,487 |
| Net Income | $-82,175 | $-76,614 | $-65,581 | $-70,752 | $-62,487 |
| EPS Basic Total Ops | -0.94 | -0.95 | -0.82 | -0.89 | -0.82 |
| EPS Basic Continuous Ops | -0.94 | -0.95 | -0.82 | -0.90 | -0.82 |
| EPS Diluted Total Ops | -0.94 | -0.95 | -0.82 | -0.89 | -0.82 |
| EPS Diluted Continuous Ops | -0.94 | -0.95 | -0.82 | -0.90 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.95 | -0.82 | -0.88 | -0.82 |
| EBITDA(a) | $-92,560 | $-84,594 | $-74,903 | $-82,035 | $-73,760 |